Would you consider pharmacotherapy (i.e., GLP1-agonist) or behavioral/nutrition interventions alone in a patient with a remote history of a restrictive eating disorder now presenting with obesity and metabolic complications?   

I would consider both pharmacotherapy and lifestyle interventions in a patient with a remote history of an eating disorder. BUT, this should be done by obesity medicine specialists who are better trained to evaluate the patient, prescribe appropriate measures and monitor the patient carefully. Alter...